Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

ONO PHARMACEUTICAL CO., LTD. (4528)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (JPY)
Sales 2018 260 B
EBIT 2018 -
Net income 2018 46 364 M
Finance 2018 111 B
Yield 2018 1,89%
Sales 2019 276 B
EBIT 2019 -
Net income 2019 49 773 M
Finance 2019 132 B
Yield 2019 1,92%
P/E ratio 2018 28,02
P/E ratio 2019 25,83
EV / Sales2018 4,75x
EV / Sales2019 4,41x
Capitalization 1 349 B
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine.The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan. 
Sector
Pharmaceuticals
Calendar
05/10Earnings Release
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
04/19ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts Supplemental Biol..
PU
04/18ONO PHARMACEUTICAL : U.S. Food and Drug Administration Approves Opdivo® (nivolum..
PU
04/17ONO PHARMACEUTICAL : Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of..
PU
04/17ONO PHARMACEUTICAL : In CheckMate -141, Opdivo (nivolumab) Demonstrated Sustaine..
PU
04/16ONO PHARMACEUTICAL : Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Sup..
PU
04/12ONO PHARMACEUTICAL : Patent Application Titled "Method for Extracting Lead Compo..
AQ
04/12ONO PHARMACEUTICAL : Karyopharm's Selinexor Receives Fast Track Designation from..
PU
04/05ONO PHARMACEUTICAL : Patent Application Titled "Process for Producing Purinone D..
AQ
04/05ONO PHARMACEUTICAL : Researchers Submit Patent Application, "Method for Producin..
AQ
03/28ONO PHARMACEUTICAL CO., LTD. : Ex-dividend day for for final dividend
FA
More news
Sector news : Generic Pharmaceuticals
04/21TAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
More sector news : Generic Pharmaceuticals
Latest Tweets
04/19ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts Supplemental B.. 
04/18ONO PHARMACEUTICAL : U.S. Food and Drug Administration Approves Opdivo® (nivo.. 
04/17ONO PHARMACEUTICAL : In CheckMate -141, Opdivo (nivolumab) Demonstrated Susta.. 
02/20Binimetinib (Array BioPharma/Pierre Fabre/Ono Pharmaceutical) Drug Analysis 2.. 
02/20Binimetinib (Array BioPharma/Pierre Fabre/Ono Pharmaceutical) Drug Analysis 2.. 
More tweets
Qtime:37
News from SeekingAlpha
03/23Alzheon Files To Raise $80 Million In U.S. IPO 
03/14Ono Pharma exercises option for Merus Biclonics technology for autoimmune bis.. 
2017Ono Pharmaceutical Needs To Reinvest Its Windfall 
2017YOUR DAILY PHARMA SCOOP : Axovant's Promised Upside, Gilead's Whistleblower Trou.. 
2017Only Bristol Bucks Big Pharma's Drive For External Reliance 
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 3 187  JPY
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director & Executive Vice President
Isao Ono Director & Managing Executive Officer
Kei Sano Director & Senior Executive Officer
Sector and Competitors